RT Journal Article
SR Electronic
T1 Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000698
DO 10.1136/jitc-2020-000698
VO 8
IS 2
A1 Crespo-Rodriguez, Eva
A1 Bergerhoff, Katharina
A1 Bozhanova, Galabina
A1 Foo, Shane
A1 Patin, Emmanuel C
A1 Whittock, Harriet
A1 Buus, Richard
A1 Haider, Syed
A1 Muirhead, Gareth
A1 Thway, Khin
A1 Newbold, Kate
A1 Coffin, Robert S
A1 Vile, Richard G
A1 Kim, Dae
A1 McLaughlin, Martin
A1 Melcher, Alan A
A1 Harrington, Kevin J
A1 Pedersen, Malin
YR 2020
UL http://jitc.bmj.com/content/8/2/e000698.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.